Skip to main content
. 2014 Jan 20;9(1):e85890. doi: 10.1371/journal.pone.0085890

Figure 5. Biological activity of the purified FGF19 proteins.

Figure 5

(A) Hepatic Cyp7a1 mRNA levels in mice 2 hrs after tail vein injection of vehicle (saline), FGF19 (10 µg/kg and 100 µg/kg body weight) *P<0.05, significant difference compared to vehicle-treated group. (B) Dose-dependency in activating ERK1/2 kinase in HepG2 cells by recombinant FGF19 for 2 hrs. (C) Time course in activating ERK1/2 kinase in HepG2 cells by 10 µg/ml FGF19.